Is USANA Health Stock a Good Investment?
USANA Health Investment Advice | USNA |
- Examine USANA Health's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research USANA Health's leadership team and their track record. Good management can help USANA Health navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Personal Care Products space and any emerging trends that could impact USANA Health's business and its evolving consumer preferences.
- Compare USANA Health's performance and market position to its competitors. Analyze how USANA Health is positioned in terms of product offerings, innovation, and market share.
- Check if USANA Health pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about USANA Health's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in USANA Health Sciences stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if USANA Health Sciences is a good investment.
Sell | Buy |
Hold
Market Performance | Very Weak | Details | |
Volatility | Very steady | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Very Low | Details | |
Economic Sensitivity | Follows the market closely | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Hold | Details | |
Financial Strenth (F Score) | Healthy | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Possible Manipulator | Details |
Examine USANA Health Stock
Researching USANA Health's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 42.0% of the company outstanding shares are owned by insiders. The company has Price to Book (P/B) ratio of 1.43. Historically many companies with similar price-to-book (P/B) ratio do better than the market in the long run. USANA Health Sciences has Price/Earnings To Growth (PEG) ratio of 1.21. The entity had not issued any dividends in recent years. The firm had 2:1 split on the 23rd of November 2016.
To determine if USANA Health is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding USANA Health's research are outlined below:
| USANA Health generated a negative expected return over the last 90 days | |
| About 58.0% of the company outstanding shares are owned by institutional investors | |
| Latest headline from kalkinemedia.com: Health Enthusiasts and Experts Unite at the USANA Health Symposium |
USANA Health Quarterly Gross Profit |
|
USANA Health uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in USANA Health Sciences. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to USANA Health's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 6th of February 2024 Upcoming Quarterly Report | View | |
| 23rd of April 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 6th of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Earnings surprises can significantly impact USANA Health's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises USANA Health's investors have experienced.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2000-04-20 | 2000-03-31 | 0.04 | 0.03 | -0.01 | 25 | ||
2000-01-27 | 1999-12-31 | 0.05 | 0.06 | 0.01 | 20 | ||
1998-10-14 | 1998-09-30 | 0.04 | 0.05 | 0.01 | 25 | ||
1998-07-14 | 1998-06-30 | 0.04 | 0.05 | 0.01 | 25 | ||
1998-04-30 | 1998-03-31 | 0.03 | 0.04 | 0.01 | 33 | ||
2009-04-28 | 2009-03-31 | 0.2 | 0.22 | 0.02 | 10 | ||
2004-02-03 | 2003-12-31 | 0.14 | 0.16 | 0.02 | 14 | ||
2011-07-26 | 2011-06-30 | 0.4 | 0.44 | 0.04 | 10 |
Know USANA Health's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as USANA Health is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading USANA Health Sciences backward and forwards among themselves. USANA Health's institutional investor refers to the entity that pools money to purchase USANA Health's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Charles Schwab Investment Management Inc | 2024-09-30 | 179 K | Assenagon Asset Management Sa | 2024-09-30 | 124 K | Ubs Group Ag | 2024-06-30 | 123.1 K | Northern Trust Corp | 2024-09-30 | 116.7 K | Jacobs Levy Equity Management, Inc. | 2024-09-30 | 110.5 K | Citadel Advisors Llc | 2024-09-30 | 107.8 K | Bank Of New York Mellon Corp | 2024-06-30 | 97.4 K | Amvescap Plc. | 2024-06-30 | 86.6 K | Numerai Gp Llc | 2024-09-30 | 67.7 K | Blackrock Inc | 2024-06-30 | 1.8 M | Vanguard Group Inc | 2024-09-30 | 1.6 M |
USANA Health's market capitalization trends
The company currently falls under 'Small-Cap' category with a current market capitalization of 760.48 M.Market Cap |
|
USANA Health's profitablity analysis
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | 0.15 | 0.28 | |
| Return On Capital Employed | 0.27 | 0.26 | |
| Return On Assets | 0.13 | 0.25 | |
| Return On Equity | 0.18 | 0.17 |
Determining USANA Health's profitability involves analyzing its financial statements and using various financial metrics to determine if USANA Health is a good buy. For example, gross profit margin measures USANA Health's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of USANA Health's profitability and make more informed investment decisions.
USANA Health's Earnings Breakdown by Geography
Please note, the presentation of USANA Health's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, USANA Health's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of USANA Health's management manipulating its earnings.
Evaluate USANA Health's management efficiency
USANA Health Sciences has return on total asset (ROA) of 0.0809 % which means that it generated a profit of $0.0809 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.1083 %, meaning that it created $0.1083 on every $100 dollars invested by stockholders. USANA Health's management efficiency ratios could be used to measure how well USANA Health manages its routine affairs as well as how well it operates its assets and liabilities. At present, USANA Health's Return On Tangible Assets are projected to slightly decrease based on the last few years of reporting. The current year's Return On Assets is expected to grow to 0.25, whereas Return On Capital Employed is forecasted to decline to 0.26. At present, USANA Health's Total Assets are projected to increase significantly based on the last few years of reporting. The current year's Non Currrent Assets Other is expected to grow to about 57.6 M, whereas Non Current Assets Total are forecasted to decline to about 110.8 M.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 20.31 | 21.32 | |
| Tangible Book Value Per Share | 17.98 | 18.88 | |
| Enterprise Value Over EBITDA | 6.56 | 9.96 | |
| Price Book Value Ratio | 2.71 | 2.58 | |
| Enterprise Value Multiple | 6.56 | 9.96 | |
| Price Fair Value | 2.71 | 2.58 | |
| Enterprise Value | 101.6 M | 96.5 M |
Leadership effectiveness at USANA Health Sciences is a strong indicator of its financial stability. We analyze various metrics to provide insights into the stock's investment viability.
Beta 0.888 |
Basic technical analysis of USANA Stock
As of the 25th of November, USANA Health owns the downside deviation of 2.16, and Risk Adjusted Performance of 0.0208. In relation to fundamental indicators, the technical analysis model makes it possible for you to check practical technical drivers of USANA Health Sciences, as well as the relationship between them.USANA Health's insider trading activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific USANA Health insiders, such as employees or executives, is commonly permitted as long as it does not rely on USANA Health's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases USANA Health insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
USANA Health's Outstanding Corporate Bonds
USANA Health issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. USANA Health Sciences uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most USANA bonds can be classified according to their maturity, which is the date when USANA Health Sciences has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| HSBC Holdings PLC Corp BondUS404280DR76 | View | |
| UPC HLDG BV Corp BondUS90320LAG23 | View | |
| USAACA 3375 01 MAY 25 Corp BondUS90327QD891 | View | |
| US90327QD552 Corp BondUS90327QD552 | View | |
| US90320WAD56 Corp BondUS90320WAD56 | View | |
| US90320BAA70 Corp BondUS90320BAA70 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View |
Understand USANA Health's technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing USANA Health's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | 0.0208 | |||
| Market Risk Adjusted Performance | 0.0446 | |||
| Mean Deviation | 1.71 | |||
| Semi Deviation | 2.02 | |||
| Downside Deviation | 2.16 | |||
| Coefficient Of Variation | 5334.35 | |||
| Standard Deviation | 2.17 | |||
| Variance | 4.71 | |||
| Information Ratio | (0.04) | |||
| Jensen Alpha | (0.08) | |||
| Total Risk Alpha | (0.31) | |||
| Sortino Ratio | (0.04) | |||
| Treynor Ratio | 0.0346 | |||
| Maximum Drawdown | 9.68 | |||
| Value At Risk | (3.59) | |||
| Potential Upside | 3.62 | |||
| Downside Variance | 4.65 | |||
| Semi Variance | 4.06 | |||
| Expected Short fall | (1.86) | |||
| Skewness | 0.2526 | |||
| Kurtosis | (0.02) |
| Risk Adjusted Performance | 0.0208 | |||
| Market Risk Adjusted Performance | 0.0446 | |||
| Mean Deviation | 1.71 | |||
| Semi Deviation | 2.02 | |||
| Downside Deviation | 2.16 | |||
| Coefficient Of Variation | 5334.35 | |||
| Standard Deviation | 2.17 | |||
| Variance | 4.71 | |||
| Information Ratio | (0.04) | |||
| Jensen Alpha | (0.08) | |||
| Total Risk Alpha | (0.31) | |||
| Sortino Ratio | (0.04) | |||
| Treynor Ratio | 0.0346 | |||
| Maximum Drawdown | 9.68 | |||
| Value At Risk | (3.59) | |||
| Potential Upside | 3.62 | |||
| Downside Variance | 4.65 | |||
| Semi Variance | 4.06 | |||
| Expected Short fall | (1.86) | |||
| Skewness | 0.2526 | |||
| Kurtosis | (0.02) |
Consider USANA Health's intraday indicators
USANA Health intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of USANA Health stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
USANA Health Corporate Filings
F4 | 18th of November 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
8K | 22nd of October 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
| 21st of October 2024 Other Reports | ViewVerify | |
10Q | 6th of August 2024 Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations | ViewVerify |
USANA Stock media impact
Far too much social signal, news, headlines, and media speculation about USANA Health that are available to investors today. That information is available publicly through USANA media outlets and privately through word of mouth or via USANA internal channels. However, regardless of the origin, that massive amount of USANA data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of USANA Health news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of USANA Health relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to USANA Health's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive USANA Health alpha.
USANA Health Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards USANA Health can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
USANA Health Sciences Historical Investor Sentiment
Investor biases related to USANA Health's public news can be used to forecast risks associated with an investment in USANA. The trend in average sentiment can be used to explain how an investor holding USANA can time the market purely based on public headlines and social activities around USANA Health Sciences. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
USANA Health's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for USANA Health and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average USANA Health news discussions. The higher the estimate score, the more favorable the investor's outlook on USANA Health.
USANA Health Corporate Directors
| Andrew Masuda | Director Relations | Profile | |
| Peggie Pelosi | Independent Director | Profile | |
| Frederic Winssinger | Independent Director | Profile | |
| Feng Peng | Independent Director | Profile |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in USANA Health Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Is Personal Care Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of USANA Health. If investors know USANA will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about USANA Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.06) | Earnings Share 2.83 | Revenue Per Share 45.085 | Quarterly Revenue Growth (0.06) | Return On Assets 0.0809 |
The market value of USANA Health Sciences is measured differently than its book value, which is the value of USANA that is recorded on the company's balance sheet. Investors also form their own opinion of USANA Health's value that differs from its market value or its book value, called intrinsic value, which is USANA Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because USANA Health's market value can be influenced by many factors that don't directly affect USANA Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
In summary, please note that there is a difference between USANA Health's value and its price, as these two are different measures arrived at by various means. Investors typically determine if USANA Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, USANA Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.